Discount Products: Look through products available for a 25% – 50% discount in 2020. The items provided on a first come, first serve basis. View Discounted Products
Sphere Fluidics aims to develop technology that enables leading-edge research and accelerates biopharmaceutical discovery. We do this by providing novel single-cell analysis systems for the rapid screening and characterisation of single cells. Our patented picodroplet technology is specifically designed to increase chances of finding that rare molecule or cell that can lead to a life-changing medicine.
Founded in 2010, Sphere Fluidics is an established Life Sciences company, originally spun out from the University of Cambridge. We initially developed 25 patented products – biochips and specialist chemicals – which currently assist hundreds of customers globally with their research.
Started by producing novel biochip systems and providing R&D services, we have now extended our expertise and are developing a technology platform that enables discovery in a range of growing markets through single cell analysis. Our systems make the development of new biopharmaceuticals faster and more cost-effective, improve monoclonal antibody screening, cell line development, and overall research efficiency in a number of other applications including synthetic biology, single cell diagnostics, prognostics and single cell genome editing.